Mucodrill Sans Sucre Édulcoré Au Sucralose (Acetylcysteine)

Acetylcysteine, the active ingredient in Mucodrill Sans Sucre Édulcoré Au Sucralose, is a mucolytic presented as an oral formulation for oral use. It reduces the viscosity of respiratory secretions, facilitating clearance in patients with acute or chronic bronchial conditions, chronic obstructive pulmonary disease, and other respiratory tract infections.

GNH USA supplies Mucodrill Sans Sucre Édulcoré Au Sucralose as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, including Europe, Asia and the Americas, with a focus on quality assurance and regulatory compliance.

Acetylcysteine is used as a mucolytic agent in disorders characterized by thickened respiratory secretions.

- Acute bronchitis: helps loosen mucus, improving cough clearance. - Chronic bronchitis: reduces mucus viscosity, facilitating expectoration and reducing airway obstruction. - Chronic obstructive pulmonary disease (COPD): aids in mucus clearance, supporting breathing efficiency. - Respiratory tract infections: assists in clearing secretions, potentially easing symptoms.

Acetylcysteine may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Nausea: mild stomach upset after oral intake. - Vomiting: occasional expulsion of stomach contents. - Diarrhea: loose stools. - Abdominal discomfort: cramping or pain. - Taste disturbance: a sulfurous or unpleasant taste.

Serious or Rare Side Effects: - Allergic reactions: rash, urticaria, or angioedema. - Bronchospasm: tightening of airway muscles, especially in asthmatic patients. - Severe gastrointestinal bleeding: rare but reported. - Hepatic dysfunction: abnormal liver enzymes in isolated cases.

When prescribing acetylcysteine, clinicians should consider several precautionary measures to ensure safe use.

- Assess renal function: dose adjustment may be needed in severe impairment. - Monitor for bronchospasm: especially in patients with asthma or reactive airway disease. - Evaluate allergy history: avoid in individuals with known hypersensitivity to acetylcysteine or sulfhydryl compounds. - Use with caution in pregnancy: limited data, weigh potential benefits against risks. - Avoid concomitant use with activated charcoal: may reduce drug absorption. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Acetylcysteine can influence the activity of certain medicines, requiring attention to possible interactions.

Major Interactions (Avoid): - Nitroglycerin: may potentiate hypotensive effects. - Anticoagulants (e.g., warfarin): increased risk of bleeding due to enhanced anticoagulant effect.

Moderate Interactions (Monitor Closely): - Inhaled bronchodilators: possible reduction in efficacy if administered simultaneously. - Antibiotics (e.g., aminoglycosides): monitor renal function as combined use may affect kidney. - Activated charcoal: may adsorb acetylcysteine, decreasing its bioavailability.